These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 10226319

  • 1. [Creutzfeldt-Jakob disease: diagnostic value of protein 14-3-3 and neuronal specific enolase assay in cerebrospinal fluid].
    Brandel JP, Beaudry P, Delasnerie-Lauprêtre N, Laplanche JL.
    Rev Neurol (Paris); 1999 Feb; 155(2):148-51. PubMed ID: 10226319
    [Abstract] [Full Text] [Related]

  • 2. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid.
    Collins S, Boyd A, Fletcher A, Gonzales M, McLean CA, Byron K, Masters CL.
    J Clin Neurosci; 2000 May; 7(3):203-8. PubMed ID: 10833616
    [Abstract] [Full Text] [Related]

  • 3. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients.
    Kenney K, Brechtel C, Takahashi H, Kurohara K, Anderson P, Gibbs CJ.
    Ann Neurol; 2000 Sep; 48(3):395-8. PubMed ID: 10976650
    [Abstract] [Full Text] [Related]

  • 4. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.
    Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG.
    N Engl J Med; 1996 Sep 26; 335(13):924-30. PubMed ID: 8782499
    [Abstract] [Full Text] [Related]

  • 5. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.
    Satoh K, Shirabe S, Tsujino A, Eguchi H, Motomura M, Honda H, Tomita I, Satoh A, Tsujihata M, Matsuo H, Nakagawa M, Eguchi K.
    Dement Geriatr Cogn Disord; 2007 Sep 26; 24(3):207-12. PubMed ID: 17690553
    [Abstract] [Full Text] [Related]

  • 6. New diagnostic tests for prion diseases.
    Collinge J.
    N Engl J Med; 1996 Sep 26; 335(13):963-5. PubMed ID: 8782506
    [No Abstract] [Full Text] [Related]

  • 7. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Harrington MG, Merril CR, Asher DM, Gajdusek DC.
    N Engl J Med; 1986 Jul 31; 315(5):279-83. PubMed ID: 3523251
    [Abstract] [Full Text] [Related]

  • 8. Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease.
    Aksamit AJ, Preissner CM, Homburger HA.
    Neurology; 2001 Aug 28; 57(4):728-30. PubMed ID: 11524493
    [Abstract] [Full Text] [Related]

  • 9. [Clinical algorithm for cerebrospinal fluid test of 14-3-3 protein in diagnosis of Creutzfeldt-Jacob disease].
    Lemstra AW, van Meegen M, Baas F, van Gool WA.
    Ned Tijdschr Geneeskd; 2001 Jul 28; 145(30):1467-71. PubMed ID: 11503317
    [Abstract] [Full Text] [Related]

  • 10. Autopsy-proven Creutzfeldt-Jakob disease in a patient with a negative 14-3-3 assay and nonspecific EEG and MRI.
    Donahue JE, Hanna PA, Hariharan S.
    Neurol Sci; 2004 Feb 28; 24(6):411-3. PubMed ID: 14767688
    [Abstract] [Full Text] [Related]

  • 11. [Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeld-Jakob disease].
    Sáiz A, Marín C, Tolosa E, Graus F.
    Neurologia; 1998 Feb 28; 13(7):324-8. PubMed ID: 9810794
    [Abstract] [Full Text] [Related]

  • 12. [Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease].
    Bernheimer H, Gatterbauer B, Radbauer C, Budka H.
    Wien Med Wochenschr; 1998 Feb 28; 148(4):96-100. PubMed ID: 9611349
    [Abstract] [Full Text] [Related]

  • 13. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.
    Noguchi-Shinohara M, Hamaguchi T, Kitamoto T, Sato T, Nakamura Y, Mizusawa H, Yamada M.
    Neurology; 2007 Jul 24; 69(4):360-7. PubMed ID: 17646628
    [Abstract] [Full Text] [Related]

  • 14. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.
    Krasnianski A, Meissner B, Schulz-Schaeffer W, Kallenberg K, Bartl M, Heinemann U, Varges D, Kretzschmar HA, Zerr I.
    Arch Neurol; 2006 Jun 24; 63(6):876-80. PubMed ID: 16769870
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid.
    Zerr I, Bodemer M, Otto M, Poser S, Windl O, Kretzschmar HA, Gefeller O, Weber T.
    Lancet; 1996 Sep 28; 348(9031):846-9. PubMed ID: 8826809
    [Abstract] [Full Text] [Related]

  • 16. 14-3-3 protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages.
    Shiga Y, Wakabayashi H, Miyazawa K, Kido H, Itoyama Y.
    J Clin Neurosci; 2006 Jul 28; 13(6):661-5. PubMed ID: 16815706
    [Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid 14-3-3 protein: variability of sporadic Creutzfeldt-Jakob disease, laboratory standards, and quantitation.
    Aksamit AJ.
    Arch Neurol; 2003 Jun 28; 60(6):803-4. PubMed ID: 12810481
    [No Abstract] [Full Text] [Related]

  • 18. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B, Boons J, Cras P.
    Clin Neurol Neurosurg; 2005 Aug 28; 107(5):355-60. PubMed ID: 16023527
    [Abstract] [Full Text] [Related]

  • 19. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.
    Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Sáanchez-Valle R, Mitrováa E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Bodemer M, Slivarichová D, Saiz A, Calero M, Ingrosso L, Knight R, Janssens AC, van Duijn CM, Zerr I.
    Neurology; 2006 Aug 22; 67(4):637-43. PubMed ID: 16924018
    [Abstract] [Full Text] [Related]

  • 20. [Cerebrospinal fluid neuron-specific enolase as a useful indicator for the early diagnosis of Creutzfeldt-Jakob disease].
    Shibuya S, Wakayama Y, Jimi T.
    Rinsho Shinkeigaku; 1997 Jul 22; 37(7):656; author reply 657. PubMed ID: 9396368
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.